NALP6, a constituent of the NOD-like receptor (NLR) family, plays a pivotal role in the innate immune response through its involvement in inflammasome formation. This protein is integral to the immune system's first line of defense, orchestrating the activation of caspase-1, which in turn facilitates the maturation and release of pro-inflammatory cytokines such as IL-1β and IL-18. Beyond its crucial function in inflammation, NALP6 is implicated in maintaining gut microbiota homeostasis and epithelial integrity, underscoring its broader impact on physiological processes. The activation of NALP6 and its subsequent assembly into inflammasomes is a tightly regulated process, initiated by specific triggers that include microbial motifs, changes in intracellular ion concentrations, or cellular stress signals. These activators prompt NALP6 to undergo conformational changes, enabling it to recruit and interact with adaptor proteins like ASC and pro-caspase-1, culminating in the formation of the inflammasome complex.
The activation mechanisms of NALP6 hinge on the detection of diverse signals, reflecting its role as a sensor for cellular stress and microbial invasion. Upon activation, NALP6 engages in oligomerization, a critical step for the assembly of the inflammasome complex. This oligomerization process allows for the recruitment of adaptor proteins and the activation of caspase-1, leading to the cleavage of pro-IL-1β and pro-IL-18 into their active forms. Additionally, NALP6 activation is modulated by intracellular signaling pathways that influence its expression and activity, including but not limited to NF-κB and various kinases. These pathways can be activated by extracellular signals or changes in the cellular environment, further influencing the activity of NALP6. Furthermore, post-translational modifications of NALP6, such as ubiquitination or phosphorylation, may regulate its ability to initiate inflammasome assembly, adding another layer of complexity to its activation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
ADP | 58-64-0 | sc-507362 | 5 g | $54.00 | ||
ATP can stimulate purinergic receptors, potentially influencing NALP6 activation through calcium influx. | ||||||
Imiquimod | 99011-02-6 | sc-200385 sc-200385A | 100 mg 500 mg | $67.00 $284.00 | 6 | |
Imiquimod activates TLR7 and TLR8, indirectly impacting NALP6 and inflammasome activation. | ||||||
Lipopolysaccharide, E. coli O55:B5 | 93572-42-0 | sc-221855 sc-221855A sc-221855B sc-221855C | 10 mg 25 mg 100 mg 500 mg | $98.00 $171.00 $425.00 $1560.00 | 12 | |
LPS stimulates TLR4, indirectly affecting NALP6 through downstream immune response pathways. | ||||||
A 438079 hydrochloride | 899507-36-9 | sc-203788B sc-203788 sc-203788C sc-203788A | 5 mg 10 mg 25 mg 50 mg | $125.00 $215.00 $430.00 $785.00 | 13 | |
This compound inhibits the P2X7 receptor, disrupting ATP-induced signaling events that indirectly affect NALP6. | ||||||
Rotenone | 83-79-4 | sc-203242 sc-203242A | 1 g 5 g | $89.00 $259.00 | 41 | |
Rotenone inhibits mitochondrial complex I, potentially influencing processes linked to NALP6 activation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin activates autophagy, potentially affecting NALP6 activity by regulating cellular homeostasis. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone influences inflammatory pathways, indirectly affecting NALP6 activity in immune responses. | ||||||